Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: A case-control study

European Journal of Neurology

Volumn 19, Issue 2, 2012, Pages 241-247

  Harirchian, M H ^a   Tekieh, A H ^a   Modabbernia, A ^a   Aghamollaii, V ^a   Tafakhori, A ^a   Ghaffarpour, M ^a   Sahraian, M A ^b   Naji, M ^c   Yazdanbakhsh, M ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KHARAZMI UNIVERSITY   (Iran)

Author keywords

Demyelinating diseases; Multiple sclerosis; Neurological disorders

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR AA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; REMISSION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PLATELET-DERIVED GROWTH FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 84856053948     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03476.x     Document Type: Article

References (25)

1. Mancardi G, Hart B, Roccatagliata L, et al. Demyelination and axonal damage in a non-human primate model of multiple sclerosis. J Neurol Sci 2001; 184: 41-49.
2. McQualter JL, Bernard CC. Multiple sclerosis: a battle between destruction and repair. J Neurochem 2007; 100: 295-306.
3. Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002; 3: 705-714.
4. Frost EE, Nielsen JA, Le TQ, Armstrong RC. PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. J Neurobiol 2003; 54: 457-472.
5. Bogler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A 1990; 87: 6368-6372.
6. Vana AC, Flint NC, Harwood NE, Le TQ, Fruttiger M, Armstrong RC. Platelet-derived growth factor promotes repair of chronically demyelinated white matter. J Neuropathol Exp Neurol 2007; 66: 975-988.
7. Koehler NK, Roebbert M, Dehghani K, et al. Up-regulation of platelet-derived growth factor by peripheral-blood leukocytes during experimental allergic encephalomyelitis. J Neurosci Res 2008; 86: 392-402.
8. McKinnon RD, Matsui T, Aranda M, Dubois-Dalcq M. A role for fibroblast growth factor in oligodendrocyte development. Ann N Y Acad Sci 1991; 638: 378-386.
9. Butt AM, Dinsdale J. Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo. Exp Neurol 2005; 192: 125-133.
10. Su JJ, Osoegawa M, Matsuoka T, et al. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci 2006; 243: 21-30.
11. Sarchielli P, Di Filippo M, Ercolani MV, et al. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett 2008; 435: 223-228.
12. Weinshenker BG. Natural history of multiple sclerosis. Ann Neurol 1994; 36(Suppl): S6-S11.
13. Goddard DR, Berry M, Kirvell SL, Butt AM. Fibroblast growth factor-2 induces astroglial and microglial reactivity in vivo. J Anat 2002; 200: 57-67.
14. Yim SH, Hammer JA, Quarles RH. Differences in signal transduction pathways by which platelet-derived and fibroblast growth factors activate extracellular signal-regulated kinase in differentiating oligodendrocytes. J Neurochem 2001; 76: 1925-1934.
15. Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 2004; 25: 252-262.
16. Diemel LT, Jackson SJ, Cuzner ML. Role for TGF-beta1, FGF-2 and PDGF-AA in a myelination of CNS aggregate cultures enriched with macrophages. J Neurosci Res 2003; 74: 858-867.
17. Wolswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 2002; 125: 338-349.
18. Mason JL, Toews A, Hostettler JD, et al. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol 2004; 164: 1673-1682.
19. Murtie JC, Zhou YX, Le TQ, Vana AC, Armstrong RC. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 2005; 19: 171-182.
20. Kastin AJ, Akerstrom V, Hackler L, Pan W. Different mechanisms influencing permeation of PDGF-AA and PDGF-BB across the blood-brain barrier. J Neurochem 2003; 87: 7-12.
21. Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003; 9: 540-549.
22. Pollock M, Calder C, Allpress S. Peripheral nerve abnormality in multiple sclerosis. Ann Neurol 1977; 2: 41-48.
23. Eccleston PA, Funa K, Heldin CH. Expression of platelet-derived growth factor (PDGF) and PDGF alpha- and beta-receptors in the peripheral nervous system: an analysis of sciatic nerve and dorsal root ganglia. Dev Biol 1993; 155: 459-470.
24. Itoyama Y, Webster HD, Richardson EP Jr, Trapp BD. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann Neurol 1983; 14: 339-346.
25. Cuevas P, Fernandez-Ayerdi A, Carceller F, et al. Central nervous system distribution of fibroblast growth factor injected into the blood stream. Neurol Res 1996; 18: 267-272.